Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002511:Cephalosporins / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000209:etiology*; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002511:Cephalosporins; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011239:Prednisolone; D011241:Prednisone